Noninvasive skin measurements to monitor chronic renal failure pathogenesis

Biomedicine and Pharmacotherapy

Volumn 65, Issue 4, 2011, Pages 280-285

  Portugal Cohen, Meital ^a   Oron, Miriam ^b   Ma'or, Ze'evi ^b   Boaz, Mona ^c   Shtendik, Larisa ^d   Biro, Alexander ^d   Cernes, Relu ^d   Barnea, Zvi ^d   Kazir, Ze'ev ^d   Kohen, Ron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Tamar Regional Council   (Israel)

^c Epidemiology and Research Unit   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Hemodialysis; Inflammation; Noninvasive measurements; Oxidative stress; Skin hydrophilic biomarkers; Uremic pruritus

Indexed keywords

ALBUMIN; ANTIOXIDANT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 10; PARATHYROID HORMONE; PHOSPHORUS; POTASSIUM; SKIN HYDROPHILIC BIOMARKER; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BIOLOGICAL MONITORING; BLOOD CHEMISTRY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DERMATOLOGY SEVERITY SCORE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INVASIVE PROCEDURE; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE; SAMPLING; SKIN PRURITUS; SKIN SECRETION; SKIN WASH SAMPLING; TOTAL ANTIOXIDANT SCAVENGING CAPACITY; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PRURITUS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; SKIN; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA; UREMIA; URIC ACID;

EID: 79960403252     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.02.001     Document Type: Article

References (52)

1. Udayakumar P., Balasubramanian S., Ramalingam K.S., Lakshmi C., Srinivas C.R., Mathew A.C. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 2006, 72:119-125.
2. Avermaete A., Altmeyer P., Bacharach-Buhles M. Skin changes in dialysis patients: a review. Nephrol Dial Transplant 2001, 16:2293-2296.
3. Bencini P.L., Montagnino G., Citterio A., Graziani G., Crosti C., Ponticelli C. Cutaneous abnormalities in uremic patients. Nephron 1985, 40:316-321.
4. Dyachenko P., Shustak A., Rozenman D. Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol 2006, 45:664-667.
5. Gilchrest B.A., Rowe J.W., Mihm M.C. Clinical and histological skin changes in chronic renal failure: evidence for a dialysis-resistant, transplant-responsive microangiopathy. Lancet 1980, 2:1271-1275.
6. Pico M.R., Lugo-Somolinos A., Sanchez J.L., Burgos-Calderon R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol 1992, 31:860-863.
7. Murphy M., Carmichael A.J. Renal itch. Clin Exp Dermatol 2000, 25:103-106.
8. Ponticelli C., Bencini P.L. Uremic pruritus: a review. Nephron 1992, 60:1-5.
9. Stahle-Backdahl M. Uremic pruritus. Semin Dermatol 1995, 14:297-301.
10. Boaz M., Shtendik L., Oron M., Portugal-Cohen M., Kohen R., Biro A., et al. A randomized controlled clinical trial comparing the efficacy of dead sea mineral-enriched body lotion versus two types of placebo in the treatment of cutaneous dryness, itching, peeling and tightness in hemodialysis patients (EDIT). Nephron Clin Pract 2009, 113:c169-c176.
11. Meerwaldt R., Hartog J.W., Graaff R., Huisman R.J., Links T.P., den Hollander N.C., et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005, 16:3687-3693.
12. Hricik D.E., Wu Y.C., Schulak A., Friedlander M.A. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 1996, 10:568-573.
13. Modlinger P.S., Wilcox C.S., Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004, 24:354-365.
14. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
15. Ferraro B., Galli F., Frei B., Kingdon E., Canestrari F., Rice-Evans C., et al. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. Kidney Int 2003, 63:2207-2213.
16. Clermont G., Lecour S., Lahet J., Siohan P., Vergely C., Chevet D., et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000, 47:618-623.
17. Portugal-Cohen M., Kohen R. Exposure of human keratinocytes to ischemia, hyperglycemia and their combination induces oxidative stress via the enzymes inducible nitric oxide synthase and xanthine oxidase. J Dermatol Sci 2009, 55:82-90.
18. Khan S.B., Cook H.T., Bhangal G., Smith J., Tam F.W., Pusey C.D. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 2005, 67:1812-1820.
19. Pereira B.J., Shapiro L., King A.J., Falagas M.E., Strom J.A., Dinarello C.A. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994, 45:890-896.
20. Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M., et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int 2005, 67:1216-1233.
21. Kohen R., Gati I. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology 2000, 148:149-157.
22. Cao G., Verdon C.P., Wu A.H., Wang H., Prior R.L. Automated assay of oxygen radical absorbance capacity with the COBAS FARA II. Clin Chem 1995, 41:1738-1744.
23. Prior R.L., Hoang H., Gu L., Wu X., Bacchiocca M., Howard L., et al. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 2003, 51:3273-3279.
24. Motchnik P.A., Frei B., Ames B.N. Measurement of antioxidants in human blood plasma. Methods Enzymol 1994, 234:269-279.
25. Bolton C.H., Downs L.G., Victory J.G., Dwight J.F., Tomson C.R., Mackness M.I., et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001, 16:1189-1197.
26. Bosutti A., Grassi G., Fiotti N., Guarnieri G., Biolo G. Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment. Cytokine 2007, 40:71-74.
27. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002, 30:620-650.
28. Santos C.X., Anjos E.I., Augusto O. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999, 372:285-294.
29. Fukui M., Tanaka M., Shiraishi E., Harusato I., Hosoda H., Asano M., et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008, 74:1197-1201.
30. Bonventre J.V., Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003, 14:2199-2210.
31. Squadrito G.L., Cueto R., Splenser A.E., Valavanidis A., Zhang H., Uppu R.M., et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 2000, 376:333-337.
32. Hafner J., Keusch G., Wahl C., Burg G. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998, 27:137-143.
33. Taylor J.E., Belch J.J., Henderson I.S., Stewart W.K. Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin. Int Angiol 1996, 15:33-38.
34. Droge W. Free radicals in te physiological control of cell function. Physiol Rev 2002, 82:47-95.
35. Engerson T.D., McKelvey T.G., Rhyne D.B., Boggio E.B., Snyder S.J., Jones H.P. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest 1987, 79:1564-1570.
36. Weight S.C., Bell P.R., Nicholson M.L. Renal ischaemia - reperfusion injury. Br J Surg 1996, 83:162-170.
37. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003, 140-141:105-112.
38. Negre-Salvayre A., Salvayre R., Auge N., Pamplona R., Portero-Otin M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009, 11:3071-3109.
39. Abuja P.M. Ascorbate prevents prooxidant effects of urate in oxidation of human low-density lipoprotein. FEBS Lett 1999, 446:305-308.
40. Hayden M.R., Tyagi S.C. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 2004, 1:10.
41. Grandjean-Laquerriere A., Le Naour R., Gangloff S.C., Guenounou M. Differential regulation of TNF-alpha, IL-6 and IL-10 in UVB-irradiated human keratinocytes via cyclic AMP/protein kinase A pathway. Cytokine 2003, 23:138-149.
42. Portugal-Cohen M., Soroka Y., Ma'or Z., Oron M., Zioni T., Bregegere F.M., et al. Protective effects of a cream containing Dead Sea minerals against UVB-induced stress in human skin. Exp Dermatol 2009, 18:781-788.
43. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes, IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270:9558-9563.
44. Musch W., Verfaillie L., Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2006, 1:909-914.
45. Kohen R., Oron M., Zelkowicz A., Kanevsky E., Farfouri S., Wormser U. Low molecular weight antioxidants released from the skin's epidermal layers: an age dependent phenomenon in the rat. Exp Gerontol 2004, 39:67-72.
46. Lee Y.S., Kim S.J., Oh J.K., Chung J.H., Eun H.C. Cutaneous microdialysis of uric acid level in the dermis: modification of in vitro recovery. Acta Derm Venereol 2003, 83:10-13.
47. Lundin A.P., Fani K., Berlyne G.M., Friedman E.A. Dermal angiopathy in hemodialysis patients: the effect of time. Kidney Int 1995, 47:1775-1780.
48. Gilbertson D.T., Peng Y., Bradbury B., Ebben J.P., Collins A.J. Hemoglobin level variability: anemia management among variability groups. Am J Nephrol 2009, 30:491-498.
49. Narita I., Alchi B., Omori K., Sato F., Ajiro J., Saga D., et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006, 69:1626-1632.
50. Santos N.S., Draibe S.A., Kamimura M.A., Canziani M.E., Cendoroglo M., Junior A.G., et al. Is serum albumin a marker of nutritional status in hemodialysis patients without evidence of inflammation?. Artif Organs 2003, 27:681-686.
51. de Jongh C.M., Verberk M.M., Spiekstra S.W., Gibbs S., Kezic S. Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin. Skin Res Technol 2007, 13:390-398.
52. Weber S.U., Thiele J.J., Cross C.E., Packer L. Vitamin C, uric acid, and glutathione gradients in murine stratum corneum and their susceptibility to ozone exposure. J Invest Dermatol 1999, 113:1128-1132.